ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,634, issued on Jan. 13, was assigned to Farsight Medical Technology (Shanghai) Co. Ltd. (Shanghai).
"Cyclophilin inhibitors and uses thereof" was invented by Ching-Pong Mak (Shanghai), Hans Fliri (Shanghai), Fashu Ma (Shanghai) and Michael Peel (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds defined by Formula 4 are used as cyclophilin inhibitors for the prevention or treatment of diseases or disorders, in particular diseases or conditions associated with cellular injury or cell death, such as organ injury or organ failure, which can be caused by a number of different reasons, such as ischemia or ischemia reperfusion injury, toxin...